T. Jansen

Rosacea – global diversity and optimized outcome: proposed international consensus from the Rosacea International Expert Group

B. Elewski, M. Picardo, Z. Draelos, 2011, Journal of the European Academy of Dermatology and Venereology : JEADV.

[Fabry disease: demographic data since introduction of enzyme replacement therapy].

A. Rolfs, H. Neumann, G. Sunder-Plassmann, 2007, Deutsche medizinische Wochenschrift.

Clinical presentations and classification of rosacea.

T. Jansen, 2011, Annales de dermatologie et de venereologie.

Fabry disease and the skin: data from FOS, the Fabry outcome survey

R. Jaussaud, U. Ramaswami, G. Pintos-Morell, 2007, The British journal of dermatology.

CD 28 expressing B cells and ACPA + plasmablasts /-cells of Rheumatoid arthritis patients Chapter 5

Huizinga, R. Toes, T. Jansen, 2016 .

Antinucleair antibody (ANA) positivity caused by paraneoplastic antibodies due to abundant p53 expression in early hepatic carcinoma.

A. Gouw, K. Jong, T. Jansen, 2003, The Netherlands journal of medicine.